Hydrocodone

Hydrocodone is a prescription pain medication that matters because it effectively manages moderate to severe chronic pain but carries risks of dependency and misuse.

Studies indicate hydrocodone bitartrate and its extended-release form, Hysingla ER, are effective for managing chronic pain conditions. They also highlight the importance of careful dosing due to potential respiratory depression and addiction risk. Research on pharmacodynamics and behavioral pharmacology underscores the need for cautious use in palliative care settings.

This medication is closely connected with chronic pain management and opioid dependency concerns. It also relates to gastrointestinal issues, as noted in a case report involving coin-shaped opacities in the stomach.

Evidence quality varies across studies, with some focusing more on clinical outcomes than others, indicating a need for further research into long-term effects and safety profiles.

Sources

• Hydrocodone bitartrate for chronic pain. (PMID:26261844)
• Hydrocodone Bitartrate ER (Hysingla(®) ER): A Review in Chronic Pain. (PMID:27718163)
• Hydrocodone extended-release: pharmacodynamics, pharmacokinetics and behavioral pharmacology of a controversy. (PMID:25301538)
• Extended-release hydrocodone (Hysingla ER) for pain. (PMID:25941956)
• Hydrocodone: does it have a role in palliative care? (PMID:20862909)
• Coin-Shaped Opacities in the Stomach. (PMID:37902730)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._